QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

$2.15
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
$2.06
$2.16
50-Day Range
$1.55
$4.10
52-Week Range
$0.17
$10.10
Volume
4,767 shs
Average Volume
515,543 shs
Market Capitalization
$126.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BTX stock logo

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

BTX Stock Price History

BTX Stock News Headlines

'Brooklyn Nine-Nine' star Andre Braugher dies at 61
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Brooklyn Bridge
Brooklyn Bedding Coupon for November
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Brooklyn Hospital Center
Brooklyn Technical High School
Brooklyn Preparatory High School
See More Headlines
Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Television Broadcasting
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$126.48 million
Optionable
No Data
Beta
4.61
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Matthew Angel
    President, Chief Executive Officer & Director
  • Andrew C. Jackson
    Chief Financial Officer
  • Roger Sidhu
    Chief Medical Officer
  • Jay Sial
    Chief Administrative Officer
  • Sandra Gurrola
    Principal Accounting Officer & VP-Finance

BTX Stock Analysis - Frequently Asked Questions

How have BTX shares performed in 2024?

Brooklyn ImmunoTherapeutics' stock was trading at $4.1020 on January 1st, 2024. Since then, BTX shares have decreased by 47.6% and is now trading at $2.15.
View the best growth stocks for 2024 here
.

How do I buy shares of Brooklyn ImmunoTherapeutics?

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners